As of Feb 23
| +0.11 / +1.81%|
The 7 analysts offering 12-month price forecasts for Mesoblast Ltd have a median target of 13.25, with a high estimate of 20.00 and a low estimate of 5.50. The median estimate represents a +114.05% increase from the last price of 6.19.
The current consensus among 8 polled investment analysts is to Buy stock in Mesoblast Ltd. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.